These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3688680)

  • 1. Graves disease induced by radioactive iodine.
    Kay TW; Heyma P; Harrison LC; Martin FI
    Ann Intern Med; 1987 Dec; 107(6):857-8. PubMed ID: 3688680
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism.
    van Haeften TW
    Lancet; 2003 Nov; 362(9395):1584. PubMed ID: 14615126
    [No Abstract]   [Full Text] [Related]  

  • 4. Appearance of Graves'-like disease after radioiodine therapy for toxic as well as non-toxic multinodular goitre.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):129-30. PubMed ID: 7641405
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute thyroiditis with highly positive thyrotropin receptor antibodies and high thyroidal radioactive iodine uptake.
    Fujii S; Miwa U; Seta T; Ohoka T; Mizukami Y
    Intern Med; 2003 Aug; 42(8):704-9. PubMed ID: 12924496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer.
    Filetti S; Belfiore A; Amir SM; Daniels GH; Ippolito O; Vigneri R; Ingbar SH
    N Engl J Med; 1988 Mar; 318(12):753-9. PubMed ID: 3347223
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of Graves' hyperthyroidism after radioiodine treatment for a toxic nodule: is the hyperthyroidism always triggered by 1311 therapy?
    Niepomniszcze H; Pitoia F; Goodall C; Manavela M; Bruno OD
    Thyroid; 2001 Oct; 11(10):991. PubMed ID: 11716050
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
    Gupta MK
    Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging.
    Bennedbaek FN; Gram J; Hegedüs L
    Thyroid; 1996 Oct; 6(5):457-9. PubMed ID: 8936671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gamma-camera functional scintigraphy in the differential diagnosis of Basedow's disease: results in 423 patients].
    Baum RP; Hör G
    Rontgenpraxis; 1986 Dec; 39(12):425-8. PubMed ID: 3824080
    [No Abstract]   [Full Text] [Related]  

  • 12. [The immune and nonimmune genesis of goiter].
    Grigorie D
    Endocrinologie; 1990; 28(3-4):95-106. PubMed ID: 1983320
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinction between autoimmune and nonautoimmune hyperthyroidism by determination of thyrotropin-receptor antibodies in patients with the scintigraphic diagnosis of disseminated autonomy.
    Wallaschofski H; Orda C; Führer D; Holzapfel HP; Krohn K; Miehle K; Neumann S; Georgi P; Paschke R
    Thyroid; 2001 Jul; 11(7):710-1. PubMed ID: 11484903
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential pathogenicity of autoantibodies to thyrotropin receptor in treated, euthyroid patients with Graves' disease.
    Banga JP; Harris PE
    Eur J Endocrinol; 1998 Aug; 139(2):139-42. PubMed ID: 9724064
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse of Graves' disease after subacute thyroiditis.
    Grunenberger F; Chenard MP; Weber JC; Jaeck D; Schlienger JL
    Thyroid; 1998 Aug; 8(8):683-5. PubMed ID: 9737364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual case of Marine-Lenhart syndrome.
    El-Kaissi S; Kotowicz MA; Goodear M; Wall JR
    Thyroid; 2003 Oct; 13(10):993-4. PubMed ID: 14611711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current methods of radionuclide diagnosis and radiodine therapy in toxic goiter].
    Purizhanskiĭ II; Lyzhina VD; Romanenko AM; Lisenkov PI
    Med Radiol (Mosk); 1980 Dec; 25(12):53-7. PubMed ID: 6894013
    [No Abstract]   [Full Text] [Related]  

  • 18. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
    Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
    J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSH receptor antibodies and ultrasonography in Graves' disease.
    Zingrillo M; Liuzzi A
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):387-9. PubMed ID: 7586611
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
    Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
    Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.